Who is eligible for clinical trial NCT05442840?

Participants must meet protocol criteria for Diabetes Type 2. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT05442840 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-04-16

Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes (NCT05442840)

🔵 Active, Not Recruiting Observational / Diagnostic 💊 Investigational Drug / Biologic Sponsor: University of Manitoba

🩺 Plain-English Summary (8th-Grade Level)

Type 2 diabetes is a chronic disease that can lead to a number of complications if uncontrolled and there is a projected increase of 33% patients living with diabetes over the next 10 years. There can be improvements to modifiable risk factors such as diet and exercise, in addition to medications. Treatment often involves a multidisciplinary approach with a physician, endocrinologist, dietitian, pharmacist and other support health professionals as required. This study will evaluate the effects of the pharmacists (or pharmD interns) intervention, looking at changes to the patients HbA1C, which is a measure of the patients blood glucose control over the previous 3 months as well as the patients understanding and comfort with managing their own diabetes via participant survey.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (7 items).

Location: Portage Clinic — Portage la Prairie, Manitoba

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Patients whose primary care physician is within the Portage Clinic
Adults (age 18 and older) with type 2 diabetes with HbA1C 10 % or above
Patients whom have not had previous clinical pharmacist directed intervention
Agree to participate in the study, including frequent follow up, blood glucose home monitoring as directed and repeat lab work
Willing to consider medication adjustments as deemed appropriate
Willing to review and sign the Research Participant Information and Informed Consent Form

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Patients less than 18 years of age
Patients with type 1 diabetes, pre-diabetes or gestational diabetes (or whom are pregnant)
Patients whom have had recent or ongoing clinical pharmacist directed intervention or intensive health care professional monitoring and guidance
Patients with HbA1C less than 10%
Patients whom refuse medication adjustments
Patients with severe renal impairment or receiving dialysis treatments

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Portage Clinic — Portage la Prairie, Manitoba

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗